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Studies were performed to investigate the contributions of the CC chemokine receptor CCR5 in host defense and disease
development following intracranial infection with mouse hepatitis virus (MHV). T cell recruitment was impaired in MHV-infected
CCR52/2 mice at day 7 postinfection (pi), which correlated with increased (P # 0.03) titers within the brain. However, by day 12 pi,
T cell infiltration into the CNS of infected CCR52/2 and CCR51/1 mice was similar and both strains exhibited comparable viral titers,
indicating that CCR5 expression is not essential for host defense. Following MHV infection of CCR51/1 mice, greater than 50% of
cells expressing CCR5 antigen were activated macrophage/microglia (determined by F4/80 antigen expression). In addition,
infected CCR52/2 mice exhibited reduced (P # 0.02) macrophage (CD45highF4/801) infiltration, which correlated with a significant
reduction (P # 0.001) in the severity of demyelination compared to CCR51/1 mice. These data indicate that CCR5 contributes to
MHV-induced demyelination by allowing macrophages to traffic into the CNS. © 2001 Academic Press
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INTRODUCTION
CCR5 is a member of the CC chemokine receptor family
that is expressed on various hematopoietic cells, including
lymphocytes and macrophages (Raport et al., 1996). Che-
mokines that are capable of binding to CCR5 include
CCL3 (MIP-1a), CCL4 (MIP-1b), and CCL5 (RANTES)
Boring et al., 1996; Meyer et al., 1996; Raport et al., 1996;
lotnik and Yoshie, 2000). Recent studies have impli-
ated CCR5 as an important molecule in regulating the
mmune response as well as leukocyte trafficking follow-
ng microbial infection. Mice deficient in CCR5 (CCR52/2)
exhibit altered T cell activity and impaired macrophage
function (Sato et al., 1999; Zhou et al., 1998). Furthermore,
acrophage trafficking in response to antigen is impaired
n CCR52/2 mice, indicating that CCR5 is required for mi-
gration of this population of cells (Huffnagle et al., 1999).
Mouse hepatitis virus (MHV) is a positive-strand RNA
virus that is a member of the Coronaviridae family. MHV
infection of the CNS results in an acute encephalomyeli-
tis followed by a chronic demyelinating disease that is
similar to the pathology observed in the human demyeli-
nating disease multiple sclerosis (MS) (Houtman and
Flemming, 1996; Lane and Buchmeier, 1997). A robust
expression of chemokine genes occurs within the brains
and spinal cords of MHV-infected mice which precedes
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Molecular Biology and Biochemistry, Biolog-C
d
cal Sciences II, University of California, Irvine, CA 92697-3900. Fax:
949) 824-8551. E-mail: tlane@uci.edu.
0042-6822/01 $35.00
Copyright © 2001 by Academic Press
All rights of reproduction in any form reserved.
8ltiple sclerosis; macrophage; neuroimmunology.
then accompanies leukocyte infiltration (Lane et al.,
998). Among the chemokines expressed within the CNS
f MHV-infected mice are the CCR5 ligands CCL3, CCL4,
nd CCL5, suggesting an important role for these che-
okines in attracting leukocytes into the CNS. In support
f this are studies demonstrating that treatment of MHV-
nfected mice with neutralizing antisera specific for CCL5
esulted in reduced lymphocyte infiltration into the brain
nd enhanced viral recovery (Lane et al., 2000). More-
ver, anti-CCL5 treatment resulted in decreased macro-
hage infiltration, which correlated with a significant
ecrease in the severity of demyelination. Therefore,
hese data suggested that CCL5 contributes to demyeli-
ation in MHV-infected mice by attracting macrophages
nto the CNS following binding and signaling of chemo-
ine receptors expressed on the surface of these cells.
The present study was undertaken in order to better
nderstand how CCR5 contributes to disease following
HV infection of the CNS. To this end, we have evalu-
ted the severity of neurologic disease following MHV
nfection of CCR52/2 mice (Andres et al., 2000). The
results presented indicate that MHV infection of the CNS
of CCR52/2 mice results in the development of an effec-
ive immune response, as characterized by cytokine and
hemokine gene expression and clearance of virus from
he CNS. However, both macrophage infiltration and de-
yelination was significantly reduced in MHV-infected
CR52/2 mice compared to CCR51/1 mice, indicating that
CR5 contributes to the pathogenesis of MHV-induced
emyelination by attracting macrophages into the CNS.
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HV-induced CNS disease and CCR5 expression
MHV infection of C57BL/6 mice results in an acute
ncephalomyelitis characterized by viral replication in
eurons and glial cells. Approximately 40% of infected
ice die during the acute stage of disease and surviving
ice develop a severe demyelinating disease character-
zed by persistence of viral RNA and antigen within white
atter tracts accompanied by mononuclear cell infiltra-
ion and white matter destruction. Chemokines are ex-
ressed within the CNS of MHV-infected mice and these
olecules contribute to both host defense and disease
evelopment through attraction of T cells and macro-
hages (Lane et al., 1998, 2000; Liu et al., 2000, 2001). In
rder to characterize the chemokine receptor profile in
he brains of MHV-infected mice, total RNA was isolated
t day 7 postinfection (pi) and subjected to RPA using a
ultitemplate probe set containing mouse chemokine
eceptor riboprobes. The results shown in Fig. 1 clearly
emonstrate increased expression of mRNA transcripts
FIG. 1. (A) Chemokine receptor mRNA expression in the brain follow
terile saline (sham), brains isolated at 7 days pi, and total RNA was su
ragments run higher than protected fragments due to additional cloni
ham mice are indicated at the top of the autoradiograph. Note the decr
mice compared to CCR51/1 mice. CCR5 transcripts are absent in CCR
ample sizes are as follows: CCR51/1, n 5 2; CCR52/2, n 5 2; sham, n
RNA transcripts. Densitometric analysis of each lane representing
utoradiograph (A). Data are presented as the average 6SEM.
CCR5 AND VIRAL-INor CCR1, CCR2, and CCR5 in CCR51/1 mice following
MHV infection of the CNS. As expected, CCR5 transcriptswere not expressed in CCR52/2 mice. In addition, there
was an approximate twofold reduction in mRNA tran-
script levels for both CCR1 and CCR2 in CCR52/2 mice.
Neither sham-infected CCR51/1 nor CCR52/2 mice exhib-
ted increased expression for any of the chemokine re-
eptors tested. Confocal microscopy revealed that
reater than 55% of cells positive for CCR5 also ex-
ressed F4/80 (an antigen expressed by activated micro-
lia/macrophages) (Fig. 2). CCR5 antigen was not de-
ected on F4/80-positive cells within the brains of
CR52/2 mice. Although not determined, it is likely that T
ells as well as activated astrocytes constitute the re-
aining population of CCR5-positive cells, as these cells
ave been shown to express this receptor (Mack et al.,
001; Dorf et al., 2000).
MHV infection of CCR52/2 mice
To determine the contribution of CCR5 to host defense
and neurologic disease following MHV infection of the
CNS, CCR52/2 and CCR51/1 mice were infected with
MHV and the severity of disease was evaluated. There
HV infection. CCR51/1 and CCR52/2 mice were infected with MHV or
d to RPA. The free probe set is indicated in the lefthand margin. These
ences. Each lane indicates a single mouse and infected (V5A13.1) or
levels of mRNA transcripts for CCR1 and CCR2 within infected CCR52/2
ice. The RPA shown is representative of three separate experiments.
r both groups of mice. (B) Quantitative analysis of chemokine receptor
sample from an individual mouse was performed on the scanned
9D DEMYELINATIONing M
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5 2 fo
DUCEwere no marked differences in either clinical disease
severity or mortality, with approximately 60% of CCR52/2
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gated pand CCR51/1 mice surviving until day 12 pi. Analysis of
viral titers within the brains revealed a fivefold increase
in virus present (P # 0.03) in CCR52/2 mice (5.9 6 0.1
FU/g, Log10, n 5 12) compared to CCR5
1/1 mice (5.1 6
.1 PFU/g, n 5 9) at day 7 pi (Table 1). However, by day
2 pi, there was not a significant difference in viral
urden between CCR52/2 mice (2.5 6 0.1 PFU/g, n 5 9)
and CCR51/1 mice (2.2 6 0.2 PFU/g, n 5 12) (Table 1). In
ddition, no differences were detected in the distribution
f viral antigen within the brains of infected CCR51/1 or
CCR52/2 mice at either day 7 or day 12 pi, indicating that
lack of CCR5 did not alter the cellular tropism of the virus
(data not shown). Collectively, these data indicate that
CCR5 is not essential in host defense or clearance of
virus from the brains of MHV-infected mice.
Mononuclear cell infiltration
The increased viral titers within the brains of CCR52/2
mice at day 7 pi suggested that there may be reduced
levels of infiltrating T cells present during acute disease,
as both CD41 and CD81 T cells are required for optimal
learance of virus from the CNS (Williamson and Stohl-
an, 1990; Lane et al., 2000). FACS analysis of infiltrating
ononuclear cells at day 7 pi revealed decreased infil-
ration (P # 0.03) of CD41 T cells (12.2 6 1.9%, n 5 8)
nd CD81 T cells (14.1 6 1.6%, n 5 8) into the brains of
CR52/2 mice compared to CCR51/1 mice (CD41, 19.5 6
.3%, n 5 13; CD81, 22.1 6 1.6%, n 5 13) (Table 1). By
FIG. 2. F4/80-positive cells express CCR5. CCR5 expression on F4/80
staining from brains of MHV-infected CCR51/1 and CCR52/2 mice at d
F480/CCR5-positive cells (yellow cells) is shown. Cells shown were p
3400.
FIG. 3. Demyelination is reduced in CCR52/2 mice. Representative L
ays postinfection. CCR51/1 mice (A) display mononuclear infiltration
ellular infiltration and compact myelin. Original magnification, 3200.
FIG. 4. F4/80 staining is decreased in white matter tracts of MHV-in
matter tracts of MHV-infected CCR51/1 mice (B) or CCR52/2 mice (D). F4
T
Reduced Leukocyte I
Mouse type
Days
postinfection
Brain titer
(PFU/gram tissue-Log10)
(mean 6 SEM)
CCR51/1 7 5.1 6 0.1 (9)a
12 2.2 6 0.2 (12)
CCR52/2 7 5.9 6 0.1 (12)b
12 2.5 6 0.1 (9)
a Parentheses indicate numbers of mice used. Data presented repre
b P # 0.03 when compared to CCR51/1 mice.
c Data are presented as the percentage of positive cells within the
d P # 0.001 when compared to CCR51/1 mice.
CCR5 AND VIRAL-INtracts of CCR51/1 mice compared to CCR52/2 mice. F4/80 staining of sham-infe
riginal magnification, 3200.day 12 pi, however, there were no significant differences
in the infiltration of CD41 or CD81 T cells into the CNS of
infected CCR52/2 or CCR51/1 mice (Table 1). Macro-
hage/microglial staining as assessed by F4/80 antigen
xpression was decreased by 30 and 60% in CCR52/2
mice at day 7 (CCR51/1, 27.2 6 2.4%, n 5 13; CCR52/2,
18.8 6 2.3%, n 5 8, P # 0.03) and day 12 pi (CCR51/1,
29.1 6 1.5%, n 5 3; CCR52/2, 11.8 6 0.7%, n 5 3; P #
0.001), respectively (Table 1). Collectively, these data
indicate that T cell infiltration into the CNS is affected
during acute disease in CCR52/2 mice, yet these cells
re ultimately able to enter the CNS and participate in
limination of infectious virus. Further, these data indi-
ate that macrophage/microglial activation and/or infil-
ration is compromised in the absence of CCR5.
educed macrophage infiltration and myelin
estruction in CCR52/2 mice
Previous studies have demonstrated that macro-
phages are important contributors to demyelination in
MHV-infected mice (Lane et al., 2000; Wu and Perlman,
999; Wu et al., 2000). In an effort to distinguish between
infiltrating macrophages and resident microglia, flow
analysis was performed using FITC-conjugated F4/80
antibodies and PE-conjugated CD45 antibodies. Infiltrat-
ing macrophages have been found to exhibit a
CD45highF4/801 phenotype, whereas microglia are
CD45lowF4/801 (Ford et al., 1995; Fife et al., 2000). Such
ve cells was demonstrated using confocal microscopy. Representative
for F4/80 alone (red cells), CCR5 alone (green cells), or dual-labeled
within the brain parenchyma of infected mice. Original magnification,
ning of spinal cords of MHV-infected CCR51/1 and CCR52/2 mice at 12
elin destruction, in contrast to CCR52/2 mice (B), which have limited
CCR52/2 mice. Representative staining for F4/80 antigen within white
itive cells are stained brown. Note heavy infiltration within white matter
ion in CCR52/2 Mice
ge
ry
CD41
(mean 6 SEM)
CD81
(mean 6 SEM)
F4/801
(mean 6 SEM)
105 19.5 6 1.3 (13)c 22.1 6 1.6 (13) 27.2 6 2.4 (13)
105 21.6 6 1.7 (3) 16.5 6 0.9 (3) 29.1 6 1.5 (3)
105 12.2 6 1.9 (8)b 14.1 6 1.6 (8)b 18.8 6 2.3 (8)b
106 21.0 6 2.3 (3) 21.5 6 3.7 (3) 11.8 6 0.7 (3)d
ve independent experiments.
opulation.
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oanalysis revealed an approximate threefold reduction
(P # 0.02) in numbers of infiltrating macrophages
present within the CNS of infected CCR52/2 mice at day
2 (4.5 3 104 6 8.2 3 103, n 5 5) compared CCR51/1
mice (1.3 3 105 6 1.2 3 104, n 5 4) (Table 2). In order to
determine if limited macrophage infiltration into the CNS
of infected CCR52/2 mice correlated with a reduction in
emyelination, spinal cords from infected CCR51/1 and
CCR52/2 mice at day 12 pi were stained with luxol fast
lue (LFB) and the severity of demyelination was evalu-
ted. As shown in Fig. 3B, infected CCR52/2 mice dis-
played reduced mononuclear cell infiltration into white
matter tracts which was accompanied by a marked re-
duction in the severity of demyelination compared to
CCR51/1 mice (Fig. 3A). Quantitative analysis revealed a
significant reduction (P # 0.001) in demyelination in
CCR52/2 mice (0.9 6 0.4, n 5 11) when compared to
CR51/1 mice (2.2 6 0.6, n 5 9) at day 12 pi (Table 2).
Immunohistochemical staining was performed on spinal
cord sections from both strains of mice to determine if
macrophage/microglial infiltration into white matter
tracts was reduced. The data presented in Fig. 4 reveal
intense F4/80 staining within white matter tracts of
CCR51/1 mice, while staining in CCR52/2 mice is notably
reduced.
Cytokine and chemokine gene expression in CCR51/1
and CCR52/2 mice
We next evaluated the cytokine and chemokine gene
xpression patterns in the CNS of MHV-infected CCR51/1
and CCR52/2 mice in an attempt to correlate the reduc-
ion in demyelination in CCR52/2 mice with the presence
and/or the absence of specific mRNA signals. There was
no obvious difference in the cytokine transcript profile
between the two strains of mice at either 7 or 12 days pi
(Fig. 5A). Moreover, quantification of signal intensities
revealed similar levels of transcripts for the cytokines
LT-b, TNF-a, IFN-g, and IFN-b at days 7 and 12 pi be-
ween the strains of mice (Fig. 5B). MHV-infected
CR51/1 and CCR52/2 mice expressed a similar chemo-
T
Diminished Macrophage Infiltration Correlate
Mouse type Day postinfection Average cell recove
CCR51/1 12 9.33 3 105 (4)a
CCR52/2 12 8.21 3 105 (5)
a Parentheses indicate number of mice used.
b Data are presented as the percentage of positive cells within the
c Data presented are from three independent experiments.
d P # 0.02 when compared to CCR51/1 mice.
e P # 0.001 when compared to CCR51/1 mice.
12 GLAkine profile, with CCL2 (MCP-1), CCL3, CCL5, and
CXCL10 (IP-10) being expressed at days 7 and 12 pi (Fig.
C
k6A). Analysis of transcript levels revealed comparable
mRNA abundance for each chemokine at day 7 in both
strains of mice (Fig. 6B). However, by day 12 pi, CCR52/2
mice exhibited increased levels (approximately twofold)
of mRNA transcripts for CCL5 compared to CCR51/1
mice.
DISCUSSION
Animal models of demyelination, including experimen-
tal autoimmune encephalomyelitis (EAE), Theiler’s virus-
induced demyelination, and MHV-induced demyelina-
tion, have provided valuable information with regard to
understanding the immunopathological mechanisms
contributing to human demyelinating diseases, such as
MS. We have used the MHV model of viral-induced
demyelination to better understand the complex mecha-
nisms by which chemokines and chemokine receptors
contribute to neuroinflammation, host defense, and my-
elin destruction. Through use of specific neutralizing
antibodies we have demonstrated important roles for
CXCL9 (Mig) and CXCL10 in promoting a protective Th1
response following MHV infection characterized by
CD41 and CD81 T cell infiltration and IFN-g production
(Liu et al., 2000, 2001). Further, we have shown that CCL5
erves to attract macrophages into the CNS which then
ontribute to myelin destruction (Lane et al., 2000).
herefore, chemokines clearly influence leukocyte mi-
ration and infiltration into the CNS following MHV infec-
ion and have a profound effect on the outcome of dis-
ase with regard to host defense and demyelination.
The present study was undertaken to provide informa-
ion regarding the role of chemokine receptors to MHV-
nduced neurologic disease. Instillation of MHV into the
rains of C57BL/6 mice resulted in increased mRNA
xpression of the chemokine receptors CCR1, CCR2, and
CR5 (Fig. 1). Ligands for these receptors that are ex-
ressed within the CNS of MHV-infected mice include
CL2, CCL3, CCL4, CCL5, and CCL7 (MCP-3) (Lane et
l., 1998). Therefore, these data suggest that expression
f chemokine receptors by either resident cells of the
Decreased Demyelination in CCR52/2 Mice
CD45high/F4801b (mean 6 SEM) DMc (mean 6 SEM)
1.3 3 105 6 1.2 3 104 2.2 6 0.6 (9)
4.5 3 104 6 8.2 3 103d 0.9 6 0.4 (11)e
opulation.
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SS ETNS and/or inflammatory cells in response to chemo-
ine expression may influence the immune response. We
i
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d ipts exp
f (A). Daelected to examine the role of CCR5 in MHV-induced
disease in more detail as we have recently determined
that CCL5 is important in both host defense and disease
FIG. 5. (A) Cytokine gene expression in CCR51/1 and CCR52/2 mice. M
solated at days 7 or 12 pi, and total RNA was subjected to RPA analysis. S
s follows: day 7 pi, CCR51/1, n 5 2; CCR52/2, n 5 4; day 12 pi, CCR51/1,
ays 7 and 12 pi, n 5 2. (B) Quantitative analysis of cytokine mRNA transcr
rom an individual mouse was performed on the scanned autoradiograph
FIG. 6. (A) Chemokine gene expression in CCR51/1 and CCR52/2 mice
or CCR52/2 mice at days 7 and 12 pi with MHV. RNA samples from Fig.
presented. (B) Quantitative analysis of chemokine mRNA transcripts ex
CCR5 AND VIRAL-INsample from an individual mouse was performed on the scanned autoradiog
mRNA transcripts in CCR52/2 mice compared to CCR51/1 at day 12 pi. Data adevelopment (Lane et al., 2000). In addition, the CCR5
ligand CCL3 is expressed, albeit at lower levels, during
acute disease, suggesting that this chemokine may also
e infected with either MHV or sterile saline (sham) by ic injection, brains
s a representative RPA from two separate experiments. Sample sizes are
CCR52/2, n 5 2. Results from sham mice are shown from both groups at
ressed. Densitometric analysis of each lane representing a brain sample
ta are presented as the average 6SEM.
sentative RPA showing chemokine gene expression in either CCR51/1
used to examine chemokine mRNA transcripts in the autoradiograph
d is shown. Densitometric analysis of each lane representing a brain
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re presented as the average 6SEM.
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SS ETcontribute to neuroinflammation following viral infection
of the CNS. In support of a role for CCR5 in host defense
following viral infection are studies by Dawson et al.
(2000) that have shown increased mortality in CCR52/2
mice following influenza A viral infection. Further, CCR5
expression is considered important in host defense fol-
lowing infection with Cryptococcus neoformans and Lis-
eria monocytogenes, as CCR52/2 mice exhibited in-
creased mortality and enhanced microbial recovery from
infected tissues (Huffnagle et al., 1999; Zhou et al., 1998).
oreover, recent studies have revealed important roles
or the chemokine receptors CCR1 and CCR2 in mediat-
ng host defense through leukocyte recruitment following
iral infection (Dawson et al., 2000; Domachowske et al.,
000). Collectively, these data suggest that chemokine
eceptor expression represents an important component
f host defense systems following microbial infection by
egulating leukocyte migration to sites of infection and
eplication.
MHV infection of CCR52/2 mice revealed reduced
D41 and CD81 T cell infiltration into the CNS at day 7
i, which correlated with enhanced viral recovery from
he brain (Table 1). The delay in response to infection
uring acute disease is similar to findings by Sato et al.
1999) that demonstrated a decreased host response
ollowing Leishmania donovani infection of CCR52/2
mice compared to CCR51/1 mice. However, by day 12 pi
o differences in CD41 or CD81 T cell levels were ob-
erved within the brains of infected CCR51/1 or CCR52/2
mice and both strains of mice exhibited comparable viral
titers. These data suggest that CCR5 is important in
directing T cell migration into the CNS during acute
disease but is not required for T cell infiltration at later
times. This may be the result of differential expression of
CCR5 by T cells, which is dictated by the stage of dis-
ease, e.g., acute versus chronic. Alternatively, it is pos-
sible that CCR5 signaling is important in attracting T cells
during acute disease but that T cells respond to different
chemotactic signals at later stages of disease. More
importantly, these data clearly indicate that CCR5 is not
essential in host defense following MHV infection of the
CNS. In addition, these studies illustrate the importance
of the challenging antigen/microbe with regard to the
role of CCR5 in contributing to host defense and the
outcome of infection.
Analysis of cytokine and chemokine gene expression
indicated that no differences in profiles for any of these
factors existed at either day 7 or day 12 pi (Figs. 5 and 6).
The fact that CCR52/2 mice displayed levels of IFN-g
mRNA similar to those of CCR51/1 mice despite close to
a 40% reduction in the number of T cells present in the
brains suggests that T cell production of IFN-g is in-
reased in the absence of CCR5. These results are
onsistent with those of Zhou et al. (1998) that demon-
14 GLAtrated enhanced IFN-g production by T cells obtained
from CCR52/2 mice following in vitro stimulation. Despitequivalent levels of IFN-g mRNA between the two strains
f mice at day 7, CCR52/2 mice exhibited increased viral
titers compared to CCR51/1 mice. IFN-g has been deter-
mined to exert a potent antiviral effect in MHV-infected
mice, leaving these data to be somewhat surprising.
However, it is possible that reduced levels of IFN-g
protein are present in infected CCR52/2 mice and/or that
xpression of other antiviral effector molecules such as
erforin are reduced compared to CCR51/1 mice (Lin et
l., 1997). CCR52/2 mice expressed increased levels of
RNA transcripts for CCL5 at day 12 when compared to
CR51/1 mice. These data suggest that CCR5-mediated
nd/or other chemokine receptor signaling pathways
egulate CCL5 expression, as has been suggested to
ccur in other chemokine/receptor interactions (Sallusto
t al., 2000).
It is important to note that MHV-infected CCR52/2 mice
isplayed a marked decrease in mRNA transcript levels
or CCR1 and CCR2 compared to infected CCR51/1 mice
Fig. 1). The mechanism(s) responsible for this decrease
n chemokine receptor expression is not clear. These
eceptors are expressed on activated T cells as well as
acrophages (Murphy et al., 2000). Therefore, reduced
ranscript levels for these receptors may simply reflect
he lowered levels of infiltrating T cells and macrophages
ithin the brains of infected CCR52/2 mice at day 7 pi.
Alternatively, it is possible that in the MHV model system,
CCR5 signaling may modulate expression of other che-
mokine receptors, e.g., CCR1 and/or CCR2, through the
release of soluble factor(s) which regulate chemokine
receptor expression on inflammatory cells as well as
resident cells of the CNS.
Macrophage/microglia migration into spinal cord
white matter tracts was markedly lowered within
CCR52/2 mice when compared to CCR51/1 mice (Fig. 4).
The overall reduction in activated macrophage
(CD45highF4/801) infiltration into the CNS of CCR52/2 mice
orrelated with significant reduction in the severity of
emyelination compared to CCR51/1 mice at day 12 pi
(Table 2). These data support and extend earlier studies
that have shown an important role for macrophages in
participating in myelin destruction within MHV-infected
mice (Wu and Perlman, 1999; Wu et al., 2000; Lane et al.,
2000). More importantly, the data presented in this paper
clearly indicate that CCR5 is important in contributing to
demyelination, in part by allowing macrophage migration
into the CNS following MHV infection. This is further
supported by the demonstration that the majority of F4/
80-positive cells present within the brains of MHV-in-
fected mice express CCR5 (Fig. 2). Collectively, these
data suggest that ligand binding, e.g., CCL5 and/or
CCL3, and signaling to CCR5 results in macrophage
migration and infiltration into the CNS. However, the fact
that we have previously demonstrated that CCL3 is ex-
AL.pressed only at low levels during acute disease and is
not detectable during chronic demyelination, whereas
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phases of disease, suggests that CCL5 may be the
primary CCR5 signaling chemokine in this model. This is
supported by earlier studies that showed an important
role for CCL5 in attracting macrophages into the CNS
following MHV infection (Lane et al., 2000). Therefore, the
data presented in this study suggest that one mecha-
nism by which CCL5 contributes to demyelination is via
attracting macrophages into the CNS through CCR5-
mediated signaling pathways. Additional evidence sup-
porting this is provided by the observation that even in
the presence of increased CCL5 expression at day 12 pi,
demyelination is reduced in CCR52/2 mice. This sug-
ests that CCL5 does not directly exert a toxic effect on
ligodendrocytes (the myelin-producing cell of the CNS)
ut contributes to disease by attracting CCR5-positive
acrophages into the brains and spinal cords.
Our data are in contrast with those of a recent study by
ran et al. (2000), which reports that CCR52/2 mice were
able to develop EAE following immunization with myelin
oligodendrocyte glycoprotein. No differences were de-
tected between CCR52/2 mice and CCR51/1 mice with
egard to production of Th1 cytokines, kinetics and se-
erity of disease, or leukocyte infiltration into the CNS.
his is in contrast to the results presented in this paper,
hich clearly demonstrate reduced macrophage infiltra-
ion and demyelination in MHV-infected CCR52/2 mice.
Further, Siebert et al. (2000) show that CCR52/2 mice are
indistinguishable from their wild-type counterparts with
respect to myelin density and spinal cord macrophage
infiltration following transection injury. Collectively, these
results illustrate the differences in the roles of chemo-
kines and chemokine receptors with regards to different
models of neurodegenerative disease. Although CCL5 is
expressed within the brains of mice with EAE, Kennedy
et al. (1998) demonstrated that antibody-mediated neu-
tralization of CCL5 did not affect disease outcome. In
contrast, anti-CCL5 treatment of MHV-infected mice re-
sulted in diminished macrophage migration to the CNS
and reduced demyelination (Lane et al., 2000). Therefore,
these differences emphasize the importance of using
different models of demyelination to study how chemo-
kine/chemokine receptor expression and usage influ-
ence disease outcome.
The combination of previous studies with the current
data allows for a model presentation with regard to
chemokine expression as it relates to host defense and
disease development following MHV infection of the
CNS (Lane et al., 1998; Liu et al., 2000, 2001). The T cell
hemoattractant CXCL10 is expressed very early (day 1
i) following MHV infection and serves to attract antiviral
cells into the CNS. Infiltration of activated T cells
esults in increased expression of IFN-g that promotes
xpression of another T cell chemoattractant, CXCL9.
CCR5 AND VIRAL-INoth CXCL9 and CXCL10 are important sentinel mole-
ules and serve to protect the host by attracting antiviralcells into the CNS. Expression of CCL5 increases as T
ells accumulate and this chemokine serves to attract
dditional T cells and macrophages into the CNS by
inding and signaling to CCR5 that is expressed on the
urface of these cells. Following the acute stage of dis-
ase, activated T cells are retained within the CNS and
xpress CCL5, which results in macrophage accumula-
ion and myelin destruction. Finally, these data support
nd extend earlier studies from our laboratory and others
hich indicate that strategies designed to target chemo-
ines and/or their receptors may offer unique opportuni-
ies for the treatment of neuroinflammatory diseases
uch as MS.
MATERIALS AND METHODS
irus and mice
The MHV strain V5A13.1 was kindly provided by M.
uchmeier (Scripps Research Institute, La Jolla, CA) (Dal-
iel et al., 1986). Age-matched (5–7 weeks) CCR51/1 and
CR52/2 mice (8th generation backcrossed to C57BL/6,
H-2b background) were used for all experiments. Follow-
ng anesthetization by inhalation of methoxyflurane (Pit-
an-Moor Inc., Washington Crossing, NJ), mice were
njected intracranially (ic) with 10 PFU of MHV sus-
ended in 30 ml of sterile saline (Lane et al., 1998, 2000).
ontrol (sham) animals were injected with 30 ml of sterile
aline alone. Animals were sacrificed at days 7 and 12 pi,
t which point brains and spinal cords were removed for
nalysis in studies described. One half of each brain was
sed for plaque assay on the DBT astrocytoma cell line
o determine viral burden (Hirano et al., 1978; Lane et al.,
998). The remaining halves were used for histologic
nalysis, stored at 280°C for RNA isolation, or used for
ACS analysis (Lane et al., 2000).
Immunohistochemistry
Rat anti-mouse F4/80 (Serotec, Oxford, England) [1:50
dilution in phosphate-buffered saline containing 10% nor-
mal goat serum (NGS)] was used for the detection of
activated macrophage/microglia (Lane et al., 2000). A
iotinylated secondary antibody (1:300 dilution, Vector
aboratories, Burlingame, CA) was used for visualization.
taining was performed on 6-mm-thick frozen sections
fixed in 95% ethanol for 10 min at 220°C. The ABC Elite
(Vector Laboratories) staining system was used accord-
ing to the manufacturer’s instructions, and diaminoben-
zidine (DAB) was used as a chromogen. All slides were
counterstained with hematoxylin, dehydrated, and
mounted. Staining controls were (i) omission of primary
antibodies from the staining sequence and (ii) treatment
15D DEMYELINATIONof sham-infected mice with primary and secondary anti-
bodies.
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Cells were obtained from brains of CCR51/1 and
CR52/2 mice at 7 and 12 days pi and a single cell
uspension was obtained using a previously described
ethod (Lane et al., 2000). Antibodies used for flow
ytometry in these studies included FITC rat anti-mouse
D4, CD8 (Pharmingen, San Diego, CA), F4/80 (Serotec),
nd PE-conjugated rat anti-mouse CD45 (Pharmingen).
n all cases, an isotype-matched FITC-conjugated anti-
ody was used. Cells were incubated with antibodies for
5 min at 4°C, washed, and fixed in 1% paraformalde-
yde. Following fixation, cells were analyzed on a FAC-
tar (Becton–Dickinson, Mountain View, CA) (Lane et al.,
000; Liu et al., 2000). Data are presented as the per-
entage of positive cells within the gated population.
onfocal microscopy
Primary Abs (diluted in PBS containing 10% normal
orse serum) used for dual fluorescent detection of cel-
ular Ags were as follows: rat anti-mouse F4/80 (Serotec)
t 1:50 and goat anti-mouse CCR5 (Santa Cruz Biotech-
ology, Santa Cruz, CA) at 1:50. For F4/80 primary Ab, a
RITC-conjugated secondary Ab was used (1:50; Sigma,
t. Louis, MO). For CCR5 primary Ab, a FITC-conjugated
econdary Ab was used (1:50; Zymed, South San Fran-
isco, CA). Staining was performed on 6-mm frozen sec-
tions fixed in acetone for 10 min at 220°C. Dual stained
slides were then subjected to confocal microscopy using
a Bio-Rad MRC UV laser-scanning confocal microscope
(Bio-Rad, Richmond, CA.).
Ribonuclease protection assay
Total RNA was extracted from brains of MHV-infected
CCR51/1 and CCR52/2 mice at days 7 and 12 pi. Cytokine,
hemokine, and chemokine receptor transcripts were
nalyzed using the mCK-3, mCK-5, and mCR-5 multitem-
late probe sets, respectively (Pharmingen). RPA analy-
is was performed with 15 mg of total RNA using a
previously described protocol (Lane et al., 1998, 2000).
Probes for L32 and GAPDH are included to verify con-
sistency in RNA loading and assay performance. For
quantification of signal intensity, autoradiographs were
scanned and individual chemokine, cytokine, or chemo-
kine receptor transcript bands were normalized as the
ratio of band intensity to the L32 control (Lane et al.,
1998, 2000; Liu et al., 2000). Analysis was performed
using NIH Image 1.61 software.
Histology
Spinal cords were removed at 7 and 12 days pi and
either fixed by immersion overnight in 10% normal buff-
ered Formalin (NBF) for paraffin embedding or directly
16 GLAembedded in OCT compound (Sakura Finetek, Torrence,
CA) for cryosectioning. The severity of demyelinationwas determined by LFB staining of spinal cords and
analyzed with a light microscope. LFB-stained spinal
cord sections were coded and read blind by two inves-
tigators. Demyelination was scored as follows: 0, no
demyelination: 1, mild inflammation accompanied by loss
of myelin integrity; 2, moderate inflammation with in-
creasing myelin damage; 3, numerous inflammatory le-
sions accompanied by significant increase in myelin
stripping; and 4, intense areas of inflammation accom-
panied by numerous phagocytic cells engulfing myelin
debris (Lane et al., 2000). Scores were averaged and
presented as means 6SEM.
Statistical analysis
Statistically significant differences between groups of
mice were determined by t test using Sigma-Stat 2.0
software and P values of #0.05 were considered signif-
icant.
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